Development and implementation of 3D in vitro fibrolamellar carcinoma tumor models
Timeframe: 2024 – 2025 Goals: Model development Principal Investigators: Aleksander Skardal, PhD Study overview: While researchers have made progress in treating fibrolamellar carcinoma (FLC), a big challenge remains – scientists do not have good lab models that mimic the real disease. Right now, there are very few FLC cell lines, patient-derived xenografts (PDX), or other …